Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib plus Cetuximab in HPV-negative SCCHN
NCT02499120Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of palbociclib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Pfizer. Started Sep 2015; status: completed.
02
Drugs
palbociclib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02499120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499120.